Results 251 to 260 of about 150,813 (294)
Effectiveness of a Single Fixed Dose of 3 mg Rasburicase for the Prevention and Management of Hyperuricemia in Tumor Lysis Syndrome in Adults With Cancer. [PDF]
Bakhsh S +8 more
europepmc +1 more source
Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database. [PDF]
Xia S +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Advances in Chronic Kidney Disease, 2021
Tumor lysis syndrome (TLS) is an oncologic emergency due to massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation. Clinical presentation is characterized by hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia. Acute kidney injury due to tumor lysis is potentiated
Tarek Barbar, Insara Jaffer Sathick
openaire +2 more sources
Tumor lysis syndrome (TLS) is an oncologic emergency due to massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation. Clinical presentation is characterized by hyperkalemia, hyperphosphatemia, hyperuricemia, and hypocalcemia. Acute kidney injury due to tumor lysis is potentiated
Tarek Barbar, Insara Jaffer Sathick
openaire +2 more sources
Clinical Journal of Oncology Nursing, 2004
Tumor lysis syndrome (TLS) is an oncologic emergency characterized by electrolyte and metabolic disturbances that most commonly are associated with lymphoproliferative malignancies and chemotherapy administration. It is manifested by hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia.
Diane Cope, Jeannine M. Brant
+6 more sources
Tumor lysis syndrome (TLS) is an oncologic emergency characterized by electrolyte and metabolic disturbances that most commonly are associated with lymphoproliferative malignancies and chemotherapy administration. It is manifested by hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia.
Diane Cope, Jeannine M. Brant
+6 more sources
Critical Care Nurse, 2022
Background Tumor lysis syndrome is a life-threatening oncologic emergency in adult and pediatric patients with hematologic cancer. It occurs most often in malignancies with rapid cell turnover and large tumor burden, but its incidence has risen in solid tumors.
openaire +2 more sources
Background Tumor lysis syndrome is a life-threatening oncologic emergency in adult and pediatric patients with hematologic cancer. It occurs most often in malignancies with rapid cell turnover and large tumor burden, but its incidence has risen in solid tumors.
openaire +2 more sources
Seminars in Thrombosis and Hemostasis, 2007
Tumor lysis syndrome (TLS) is an important metabolic disorder frequently encountered in the management of a variety of cancers including lymphoma, leukemia, and neuroblastoma. Delayed recognition can result in a variety of biochemical abnormalities resulting in life-threatening complications such as renal failure, arrhythmias, and seizures ...
Ramon V, Tiu +3 more
openaire +4 more sources
Tumor lysis syndrome (TLS) is an important metabolic disorder frequently encountered in the management of a variety of cancers including lymphoma, leukemia, and neuroblastoma. Delayed recognition can result in a variety of biochemical abnormalities resulting in life-threatening complications such as renal failure, arrhythmias, and seizures ...
Ramon V, Tiu +3 more
openaire +4 more sources
The Indian Journal of Pediatrics, 2012
Tumor lysis syndrome (TLS) refers to the constellation of deranged metabolic state, characterized by hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia, and/or azotemia, secondary to rapid breakdown of tumor cells. It is a life threatening emergency that typically follows administration of chemotherapy or may be spontaneous.
Aruna, Rajendran +3 more
openaire +3 more sources
Tumor lysis syndrome (TLS) refers to the constellation of deranged metabolic state, characterized by hyperkalemia, hyperphosphatemia, hyperuricemia, hypocalcemia, and/or azotemia, secondary to rapid breakdown of tumor cells. It is a life threatening emergency that typically follows administration of chemotherapy or may be spontaneous.
Aruna, Rajendran +3 more
openaire +3 more sources
2023
Le syndrome de lyse tumorale (SLT) est une urgence oncologique qui se produit lorsque les cellules cancéreuses sont rapidement détruites, provoquant des perturbations métaboliques et des complications potentiellement mortelles. Il est essentiel de prévenir et de reconnaître rapidement les TLS pour assurer une gestion efficace.
Mousa A. Al‐Abbadi, Samer Al Hadidi
openaire +2 more sources
Le syndrome de lyse tumorale (SLT) est une urgence oncologique qui se produit lorsque les cellules cancéreuses sont rapidement détruites, provoquant des perturbations métaboliques et des complications potentiellement mortelles. Il est essentiel de prévenir et de reconnaître rapidement les TLS pour assurer une gestion efficace.
Mousa A. Al‐Abbadi, Samer Al Hadidi
openaire +2 more sources
Seminars in Oncology Nursing, 1999
To review the pathophysiology, clinical manifestations, and management of tumor lysis syndrome.Published articles, case reports, and book chapters on tumor lysis syndrome.Tumor lysis syndrome is a very serious and sometimes life-threatening complication of cancer treatment. Identification of patients at risk and initiation of preventative interventions
openaire +2 more sources
To review the pathophysiology, clinical manifestations, and management of tumor lysis syndrome.Published articles, case reports, and book chapters on tumor lysis syndrome.Tumor lysis syndrome is a very serious and sometimes life-threatening complication of cancer treatment. Identification of patients at risk and initiation of preventative interventions
openaire +2 more sources
Seminars in Hematology, 2001
Tumor lysis syndrome (TLS) is a constellation of metabolic disturbances observed in tumors with high cell turnover. It is associated with significant morbidity and mortality. TLS is characterized by the increased release of intracellular contents (uric acid, potassium, phosphorus) into the extracellular compartment, which can overwhelm the body's ...
openaire +2 more sources
Tumor lysis syndrome (TLS) is a constellation of metabolic disturbances observed in tumors with high cell turnover. It is associated with significant morbidity and mortality. TLS is characterized by the increased release of intracellular contents (uric acid, potassium, phosphorus) into the extracellular compartment, which can overwhelm the body's ...
openaire +2 more sources

